NCT05526703

Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy

A Randomized, Double-blind, Multi-center, Therapeutic Confirmatory, Phase 3 Trial To Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy in Essential Hypertension Subjects Inadequately Controlled by D064 Monotherapy

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 108 (estimated)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy.

Conditions

• Essential Hypertension

Interventions

Type	Name	Description
DRUG	D064, D701, placebo of D012	Experimental Group Subjects assigned to this group are treated with D064, D701, placebo of D012
DRUG	D012, placebo of D064, placebo of D701	Comparator Group Subjects assigned to this group are treated with D012, placebo of D064, placebo of D701

Timeline

• Start date: 2022-09-28
• Primary completion: 2023-10-01
• Completion: 2023-10-01
• First posted: 2022-09-02
• Last updated: 2022-11-28

Locations

1 site across 1 country: South Korea